Matthias Lambert, PhD
@matthiaslambert
Muscle Biologist | Rare Diseases Expert | Patient-Scientist 🇫🇷🇺🇲
Past @univ_lille, @harvardmed, @BostonChildrens, & Kunkel lab team member
ID: 499661232
22-02-2012 10:31:24
2,2K Tweet
729 Takipçi
710 Takip Edilen
Harvard scientists are leaving academia for the private sector to fast-track biomedical breakthroughs. Michael Mina (eMed), Douglas Melton (Vertex), Stuart Schreiber (Arena Bioworks) cite funding delays & admin hurdles as key reasons. #BiomedicalResearch harvardmagazine.com/2025/01/harvar…
The gene-editing field may have yet another legal squabble on its hands — this time between two companies created by the same star researcher, in a dispute that illustrates the challenges facing the field. Jason Mast on Prime v. Beam statnews.com/2025/03/19/aat…
Was just fully denied the right to travel today at Liverpool St Stn, on any train, because Network Rail staff collectively refused to deploy a ramp for me. Why? One of them claimed I was “rude” for telling him I didn’t need the lecture he was giving me on why they’d failed to …
📢 [Parution] J-20 Et si, demain, on vous annonçait une maladie génétique incurable… Que feriez-vous ? Voici mon histoire. 📖 Le combat d’une vie - Éditions du Rocher 🗓️ Sortie le 19 novembre 2025 🔗 Précommande : amzn.eu/d/4FYBJFt Éditions du Rocher